Press releases

MINNEAPOLIS--(BUSINESS WIRE)--Aug. 22, 2006--Medtronic, Inc. (NYSE:MDT): -- Reported earnings of $599 million and diluted EPS of $0.51 grew 87% and 96%, respectively over the prior year's quarter....

MINNEAPOLIS--(BUSINESS WIRE)--June 2, 2006--Medtronic, Inc. (NYSE:MDT) will host an analyst and investor briefing Monday, June 12, 2006 in Washington D.C., during the American Diabetes Association...

MINNEAPOLIS--(BUSINESS WIRE)--May 23, 2006--Medtronic, Inc. (NYSE:MDT): Annual Revenue of $11.3 Billion Grew 12% (13% Constant Currency Growth); Fourth Quarter Revenue of $3.1 Billion Grew 11%...

MINNEAPOLIS--(BUSINESS WIRE)--Feb. 21, 2006--Medtronic, Inc. (NYSE:MDT): -- Company-wide Revenue Increased 9% (Constant Currency Growth of 12%) -- Implantable Cardioverter Defibrillator (ICD)...

MINNEAPOLIS--(BUSINESS WIRE)--Nov. 16, 2005--Medtronic, Inc. (NYSE:MDT): -- Implantable Cardioverter Defibrillator (ICD) Revenues Grew 34%; Worldwide Market Share Continued to Increase -- Spinal...

Medtronic, Inc. (NYSE:MDT): -- Implantable Cardioverter Defibrillator (ICD) Revenues of $682 million in the Quarter Increases Medtronic Worldwide ICD Market Share to 50 Percent -- Spinal Business...

MINNEAPOLIS--(BUSINESS WIRE)--Aug. 18, 2004-- Broad Based Growth Was Led By 31 Percent Increase In Quarterly Implantable Defibrillator Revenues Medtronic, Inc. (NYSE:MDT) today announced quarterly...

MINNEAPOLIS--(BUSINESS WIRE)--May 24, 2004--Medtronic, Inc. (NYSE:MDT) today announced record quarterly revenues of $2.665 billion, an increase of 24.1 percent over the $2.148 billion of the...

MINNEAPOLIS--(BUSINESS WIRE)--Feb. 11, 2004-- Record Quarterly Performance Led by Greater Than 15 Percent Growth in Spinal, Implantable Defibrillators, Diabetes and Vascular Drawing upon the...

MINNEAPOLIS--(BUSINESS WIRE)--Nov. 12, 2003-- Record Quarter Led by Continued Strong Growth in Implantable Defibrillator and Spinal Revenues, Together With Accelerated Growth in Diabetes; All...